Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2026-02-01–present
Board Member
Anika Therapeutics, Inc. (ANIK)Equibles does not estimate personal net worth.
Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANIK alertsStephen (Steve) Griffin is recorded as CEO and Board Member at Anika Therapeutics, Inc. (ANIK) since February 1, 2026. Anika Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Stephen (Steve) Griffin was appointed member of the Board of Directors, effective February 1, 2026. Anika Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Stephen (Steve) Griffin was appointed President and Chief Executive Officer, effective February 1, 2026. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member), Steve Griffin (CEO and Board Member) and 7 others.
“Stephen (Steve) Griffin, current Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective February 1, 2026.”
“Stephen (Steve) Griffin, current Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective February 1, 2026.”
2026-02-01–present
2026-02-01–present
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2026-02-01–present